Mixed Lineage Leukemia
2 clinical trials · Condition
◉ Watch Mixed Lineage Leukemia
| Record | Firm | Date |
|---|---|---|
| First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia (NCT04067336) | Kura Oncology, Inc. | 2019-09-12 |
| CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT (NCT03810196) | Children's Hospital of Philadelphia | 2019-03-01 |
Track Mixed Lineage Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.